Q2 Lab Solutions

What Q2 Lab Solutions does

Q2 Lab Solutions (also referenced as Q2 Solutions) is a private, for-profit clinical laboratory services company founded in 2015 and headquartered in Morrisville, North Carolina, United States. The company operates in the global flow cytometry services market — a sector valued at approximately USD 2.76 billion in 2025 — and is identified as one of roughly 30 companies providing these services, with the majority based in North America and over 70% of providers offering analysis-based flow cytometry.

The company's stated mission centers on helping customers improve human health through innovation that transforms science, and it serves drug discovery and development sponsors in the pharmaceutical and biotechnology industries. Its offering spans central laboratory services, specialty biomarker services, and flow cytometry-based analytical capabilities that support clinical trials and translational research. The company employs between 1,001 and 5,000 people, indicating a mid-to-large specialty lab footprint relative to peers in the flow cytometry services space. Co-founder and CEO Brian O'Dwyer leads the organization, with Patrice Hugo serving as Chief Scientific Officer.

Revenue mechanics are not publicly disclosed, and pricing models are not available in source materials; however, the operating profile (specialty lab services sold to pharma/biotech trial sponsors) is consistent with project- and study-based contracted revenue typical of central and specialty labs. The company is positioned within a market that industry analysts describe as actively consolidating through mergers and acquisitions, suggesting an environment of strategic transaction activity among the ~30 identified providers.

Name

Q2 Lab Solutions

Website

https://q2labsolutions.com

Company type

Private

Founded year

2015

Headcount range

1,001–5,000 employees

Short description

Q2 Lab Solutions is a private clinical laboratory services provider founded in 2015 and headquartered in Morrisville, NC, specializing in flow cytometry, biomarker, and central lab services for pharmaceutical and biotechnology drug development sponsors.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

akta.pro secondary industries

Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Clinical Research & Trial Central Laboratories (HLAFAMAL), Companion Diagnostic (CDx) Co-Development Services (biopharma partnerships, clinical strategy) (HLAAAMAB), Translational Medicine & Biomarkers (HLAIALAF)

Keywords

• Central laboratory services
• Biomarker testing services
• Clinical trial laboratory
• Bioanalytical laboratory services
• Genomics laboratory services

Headquarters

HQ city

Morrisville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Core offering

Q2 Lab Solutions provides central laboratory and specialty biomarker services for drug discovery and development, supporting pharmaceutical and biotech sponsors across clinical trial and post-approval workflows. The company combines in-depth scientific expertise, specialty lab services, and next-generation lab technologies to deliver reliable outcomes across each stage of drug development, including flow cytometry, genomics, bioanalytical, and vaccine testing services.

Differentiator

Problem solved

Functional benefit

Products and services

• Central Laboratory Services Core central lab services supporting clinical trials and drug development, including sample management, routine safety testing, and specialty assays for pharmaceutical and biotech sponsors.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered minor.

• FlowMetric Life SciencesminorOthersQ2 Solutions is profiled alongside FlowMetric Life Sciences as a key player in the global flow cytometry services market according to ResearchAndMarkets.com market report. Both companies are identified among approximately 30 companies offering flow cytometry services, with market consolidation activity increasing through mergers and acquisitions.
• Bio-LegendminorOthersBio-Legend is listed alongside Q2 Solutions in the ResearchAndMarkets.com flow cytometry services market report as one of the key industry players. Both companies compete in the global flow cytometry services market valued at USD 2.76 billion in 2025.
• ProImmuneminorOthersProImmune is identified as a key player in the global flow cytometry services market alongside Q2 Solutions in the ResearchAndMarkets.com market report. The report notes market consolidation activity through M&A in this sector.
• MLM Medical LabsminorOthersMLM Medical Labs is listed among key competitors of Q2 Solutions in the global flow cytometry services market according to ResearchAndMarkets.com market analysis. The market is experiencing consolidation through acquisitions.
• UnilabsminorOthersUnilabs is profiled as a key player in the flow cytometry services market alongside Q2 Solutions. The market report notes increased consolidation activity through mergers and acquisitions among the approximately 30 companies in this space.
• FiralisminorOthersFiralis is identified as one of approximately 30 companies offering flow cytometry services, listed alongside Q2 Solutions in the ResearchAndMarkets.com market report. The market is valued at USD 2.76 billion in 2025.
• Agilex BiolabsminorOthersAgilex Biolabs is profiled as a competitor to Q2 Solutions in the global flow cytometry services market. The market report indicates over 70% of these companies provide analysis-based flow cytometric services.

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• ICON plc (Central Laboratories): ICON operates a global central-laboratory network providing clinical-trial testing (including flow cytometry and biomarker assays) for biopharma sponsors. Directly comparable to Q2 Lab Solutions on central lab service model, sponsor customer base and global trial-testing footprint.
• Unilabs: Unilabs is profiled alongside Q2 Solutions in the ResearchAndMarkets flow cytometry services report. Comparable as a multi-region central-lab and specialty diagnostics operator serving clinical-trial and clinical-diagnostic customers.
• Eurofins Central Laboratory: Eurofins Central Laboratory offers global clinical-trial testing services including biomarkers and specialty assays for biopharma. Comparable to Q2 Lab Solutions on multi-regional central-lab service scope and biopharma sponsor focus.
• PPD / Thermo Fisher Clinical Services: Post-PPD acquisition, Thermo Fisher provides clinical-trial central lab and specialty biomarker services globally. Overlaps with Q2 Lab Solutions on sponsor-customer profile, central-lab workflows and specialty assay capabilities.
• Labcorp Central Laboratory Services (Fortrea-spin / Labcorp Drug Development heritage): Labcorp is one of the largest global central-laboratory operators supporting clinical trials across multiple therapeutic areas. Highly comparable to Q2 Lab Solutions across service mix (central lab, biomarkers, genomics) and biopharma sponsor relationships.

Direct peers

• Agilex Biolabs: Agilex Biolabs is profiled with Q2 Solutions as a flow cytometry services market player. Comparable as a bioanalytical and flow-cytometry specialty lab serving clinical-trial and translational research customers.
• MLM Medical Labs: MLM Medical Labs is explicitly listed alongside Q2 Solutions as a key player in the flow cytometry services market per ResearchAndMarkets. Direct specialty central-lab and flow-cytometry competitor with similar customer base.
• ProImmune: ProImmune is named alongside Q2 Solutions in the ResearchAndMarkets flow cytometry services market report. Directly comparable as a specialty immunology / flow cytometry service provider for biopharma research and clinical programs.
• FlowMetric Life Sciences: FlowMetric Life Sciences is identified by ResearchAndMarkets as a flow cytometry services competitor alongside Q2 Solutions. Direct peer in the analysis-based flow cytometry services niche that Q2 Lab Solutions competes in.

Regional players

• Firalis: Firalis is named as a flow cytometry services competitor alongside Q2 Solutions in the ResearchAndMarkets report. Comparable specialty central-lab and biomarker service provider, though with a more Europe-centered operational base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Q2 Lab Solutions